SPECIAL TOPIC
Integrated Heterogeneous Pd(0)-CPG Nanoparticle Catalysts
1309
The enantiomeric excess was determined by HPLC analysis in com-
parison with an authentic racemic material (ODH-column, n-hex-
ane–i-PrOH, 70:30, λ = 254 nm, 1.0 mL/min); tR (major
enantiomer) = 19.4 min; tR (minor enantiomer) = 34.6 min.
The enantiomeric excess was determined by HPLC analysis in com-
parison with an authentic racemic material (ODH-column, n-hex-
ane–i-PrOH, 98:2, λ = 230 nm, 1.0 ml/min); tR (minor
enantiomer) = 22.5 min; tR (majoror enantiomer) = 24.2 min.
1H NMR (400 MHz, CDCl3): δ = 9.97 (s, 1 H), 8.22–8.19 (m, 1 H),
7.98 (t, J = 1.2 Hz, 1 H), 7.59–7.53 (m, 2 H), 4.83 (br s, 1 H), 3.92
(s, 3 H), 3.49 (d, J = 18.8 Hz, 1 H), 3.33 (d, J = 18.8 Hz, 1 H), 2.38
(d, J = 1.6 Hz, 3 H).
13C NMR (100 MHz, CDCl3): δ = 185.8, 168.2, 159.3, 148.6, 139.0,
136.1, 134.7, 130.1, 123.8, 122.8, 117.1, 57.8, 54.8, 51.3, 48.1,
14.5.
1H NMR (400 MHz, CDCl3): δ = 9.93 (s, 1 H), 5.78 (m, 1 H), 5.08–
4.97 (m, 2 H), 3.83 (s, 3 H), 3.54 (m, 1 H), 3.22 (dd, J = 18.4, 36.3
Hz, 2 H), 2.18 (s, 3 H), 2.18–2.03 (m, 3 H), 1.88 (m, 1 H).
13C NMR (100 MHz, CDCl3): δ = 186.9, 169.3, 157.1, 137.4, 137.3,
118.1, 115.8, 54.2, 52.0, 49.3, 48.5, 31.1, 30.5, 14.1.
HRMS (ESI): m/z [M + Na] calcd for C14H17NO3 + Na: 270.1102;
found: 270.1106.
HRMS (ESI): m/z [M + Na] calcd for C16H14N2O5 + Na: 337.0792;
found: 337.0794.
Methyl (1R,2R)-1-Cyano-3-formyl-4-methyl-2-(4-methoxyphe-
nyl)cyclopent-3-enecarboxylate (4j)
Yield: 21 mg (69%); yellow oil; [α]D25 –108.7 (c = 1.6, CHCl3).
Methyl (1R,2R)-2-Butyl-1-cyano-3-formyl-4-methylcyclopent-
3-enecarboxylate (4f)
The enantiomeric excess was determined by HPLC analysis in com-
parison with an authentic racemic material (AS-H-column, n-hex-
ane–i-PrOH, 85:15, λ = 210 nm, 1.0 mL/min); tR (major
enantiomer) = 43.1 min; tR (minor enantiomer) = 73.6 min.
1H NMR (400 MHz, CDCl3): δ = 9.91 (s, 1 H), 7.08 (d, J = 8.7 Hz,
2 H), 6.88 (d, J = 8.7 Hz, 2 H), 4.68 (br s, 1 H), 3.88 (s, 3 H), 3.79
(s, 3 H), 3.38 (d, J = 18.6 Hz, 1 H), 3.24 (dt, J = 18.6, 3.0 Hz, 1 H),
2.32 (s, 3 H).
Yield: 17 mg (68%); oil; [α]D25 +30.2 (c = 1.0 CHCl3).
The enantiomeric excess was determined by HPLC analysis in com-
parison with an authentic racemic material (ODH-column, n-hex-
ane–i-PrOH, 98:2, λ = 230 nm, 1.0 mL/min); tR (major
enantiomer) = 17.7 min, tR (minor enantiomer) = 19.7 min.
1H NMR (400 MHz, CDCl3): δ = 9.93 (s, 1 H), 3.83 (s, 3 H), 3.53
(br s, 1 H), 3.26 (d, J = 18.8 Hz, 1 H), 3.13 (d, J = 20.0 Hz, 1 H),
2.18 (s, 3 H), 1.99–1.90 (m, 1 H), 1.82–1.73 (m, 1 H), 1.40–1.28 (m,
4 H), 0.90 (t, J = 6.8 Hz, 3 H).
13C NMR (100 MHz, CDCl3): δ = 186.3, 168.9, 159.8, 157.6, 136.9,
129.2, 128.6, 117.6, 114.4, 57.9, 55.3, 54.4, 51.9, 47.7, 14.3.
13C NMR (100 MHz, CDCl3): δ = 186.9, 169.5, 156.9, 137.5, 118.2,
54.2, 52.5, 49.5, 48.5, 33.4, 20.2, 14.1, 14.0.
HRMS (ESI): m/z [M + Na] calcd for C17H17NO4 + Na: 322.1050;
found: 322.1051.
HRMS (ESI): m/z [M + Na] calcd for C14H19NO3 + Na: 272.1257;
found: 272.1270.
Acknowledgment
Methyl (1R,2R)-2-(4-Bromophenyl)-1-cyano-3-formyl-4-meth-
ylcyclopent-3-enecarboxylate (4g)
We gratefully acknowledge financial support from the European
Union, Mid Sweden University, and Swedish National Research
Council. Dr. Marc Rothstein and Dr. Diane Rothstein (Prime Syn-
thesis) are acknowledged for valuable discussions. Prime Synthesis
Ltd. U.S.A. generously gave CPGs.
Yield:18 mg (52%); oil; [α]D25 –55.8 (c = 1, CHCl3).
The enantiomeric excess was determined by HPLC analysis in com-
parison with an authentic racemic material (AD-column, n-hexane–
i-PrOH, 90:10, λ = 250 nm, 1.0 mL/min); tR (major
enantiomer) = 22.3 min; tR (minor enantiomer) = 34.9 min.
1H NMR (400 MHz, CDCl3): δ = 9.91 (s, 1 H), 7.48 (d, J = 6.8 Hz,
2 H), 7.09 (d, J = 6.8 Hz, 2H), 4.67 (br s, 1 H), 3.88 (s, 3 H), 3.42
(d, J = 14.8 Hz, 1 H), 3.25 (d, J = 12.8 Hz, 1 H), 2.32 (d, J = 0.8 Hz,
1 H).
Supporting Information for this article is available online at
m
tgioSrantnugIifoop
r
itmnatr
References
13C NMR (100 MHz, CDCl3): δ = 186.0, 168.6, 158.3, 136.5, 135.7,
132.2, 129.8, 122.8, 117.3, 57.8, 54.3, 51.3, 47.9, 14.3.
(1) Corey, E. J.; Cheng, X.-M. The Logic of Chemical Synthesis;
Wiley-Interscience: New York, 1995.
HRMS (ESI): m/z [M + Na] calcd for C16H14BrNO3 + Na: 370.0049;
(2) (a) Mayer, S. F.; Kroutil, W.; Faber, K. Chem. Rev. 2006, 35,
332. (b) Ricca, E.; Brucher, B.; Schrittwieser, J. H. Adv.
Synth. Catal. 2011, 353, 2239.
(3) (a) Tietze, L. F. Chem. Rev. 1996, 96, 115. (b) Nicolaou, K.
C.; Edmonds, D. J.; Bulger, P. G. Angew. Chem. Int. Ed.
2006, 45, 7134. (c) Guo, H.; Ma, J. Angew. Chem. Int. Ed.
2006, 45, 354. (d) Ramon, D. J.; Yus, M. Angew. Chem. Int.
Ed. 2005, 44, 1602.
(4) (a) Veum, L.; Hanefeld, U. Chem. Commun. 2006, 825.
(b) Sheldon, R. A.; Arends, I.; Hanefeld, U. Green
Chemistry and Catalysis; Wiley-VCH: Weinheim, 2007.
(c) Lee, J. M.; Na, Y.; Han, H.; Chang, S. Chem. Soc. Rev.
2004, 33, 302.
(5) (a) Shao, Z.; Zhang, H. Chem. Soc. Rev. 2009, 38, 2745.
(b) Du, Z.; Shao, Z. Chem. Soc. Rev. 2013, 42, 1337.
(c) Allen, A. E.; MacMillan, D. W. C. Chem. Sci. 2012, 3,
633.
found: 370.0050.
Methyl (1R,2R)-1-Cyano-3-formyl-4-methyl-2-propylcyclo-
pent-3-enecarboxylate (4h)
Yield: 19 mg (81%); oil; [α]D25 +15.5 (c = 1.0 CHCl3).
The enantiomeric excess was determined by HPLC analysis in com-
parison with an authentic racemic material (ODH-column, n-hex-
ane–i-PrOH, 98:2, λ = 230 nm, 1.0 mL/min); tR (major
enantiomer) = 18.1 min; tR (minor enantiomer) = 19.8 min.
1H NMR (400 MHz, CDCl3): δ = 9.93 (s, 1 H), 3.83 (s, 3 H), 3.52
(m, 1 H), 3.19 (dd, J = 18.4, 36.3 Hz, 2 H), 2.42 (s, 3 H), 1.92 (m, 1
H), 1.75 (m, 1 H), 1.47–1.27 (m, 2 H), 0.94 (t, J = 6.8 Hz, 3 H).
13C NMR (100 MHz, CDCl3): δ = 186.9, 169.5, 156.9, 137.5, 118.2,
54.2, 52.5, 49.5, 48.5, 33.4, 20.2, 14.1, 14.0.
HRMS (ESI): m/z [M + Na] calcd for C13H17NO3 + Na: 258.1101;
found: 258.1109.
(6) For selected examples, see: (a) Ibrahem, I.; Córdova, A.
Angew. Chem. Int. Ed. 2006, 45, 1952. (b) Silvero, D. L.;
Torker, S.; Pilyugina, T.; Vieira, E. M.; Snapper, M. L.;
Haeffner, F.; Hoveyda, A. H. Nature 2013, 494, 216.
Methyl (1R,2R)-2-(But-3-en-1-yl)-1-cyano-3-formyl-4-methyl-
cyclopent-3-enecarboxylate (4i)
Yield: 16.5 mg (63%); oil; [α]D25 +12.3 (c = 1.0 CHCl3).
© Georg Thieme Verlag Stuttgart · New York
Synthesis 2014, 46, 1303–1310